Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-30

Clinical Trial Update: Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Aquacel Ag with Mepilex Border Ag for reducing bioburden in leg ulcers completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aquacel Ag (Aquacel Ag)
  • Mepilex Border Ag (silver-impregnated antimicrobial wound dressing)

Snippet

Sponsor: ConvaTec Inc. | Conditions: Leg Ulcers | Phase 3 | Status: COMPLETED